Quality of life in brain metastases radiation trials: a literature review
暂无分享,去创建一个
E. Chow | E. Chow | J. Wong | A. Hird | A. Kirou–Mauro | J. Napolskikh | J. Wong | A. Hird | J. Napolskikh | A. Kirou-Mauro
[1] W. Curran,et al. Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater results of radiation therapy oncology group 85–28 , 1993, Cancer.
[2] W. Mason,et al. Radiotherapy for brain metastases: defining palliative response. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[3] M. Synodinou,et al. Whole brain radiotherapy alone or in combination with temozolomide for brain metastases. a phase III study , 2002 .
[4] M. Mehta,et al. A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. , 1996, International journal of radiation oncology, biology, physics.
[5] L. Thiberville,et al. Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] A. Dobson,et al. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. , 1981, Journal of chronic diseases.
[7] M. Caraglia,et al. Concomitant treatment of brain metastasis with Whole Brain Radiotherapy [WBRT] and Temozolomide [TMZ] is active and improves Quality of Life , 2007, BMC Cancer.
[8] E. Shaw,et al. Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: Determinants of response and its prognostic value for subsequent survival. , 2006, International journal of radiation oncology, biology, physics.
[9] M. Hazuka,et al. Brain metastases: results and effects of re-irradiation. , 1988, International journal of radiation oncology, biology, physics.
[10] F. Liedberg,et al. Noncontinent urinary diversion , 2006 .
[11] S. Sehlen,et al. Quality of Life (QoL) as Predictive Mediator Variable for Survival in Patients with Intracerebral Neoplasma During Radiotherapy , 2003, Oncology Research and Treatment.
[12] M. Millward,et al. A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lung. , 2004, Lung cancer.
[13] N. Choi,et al. Improved quality of life of patients with small-cell carcinoma of the lung by elective irradiation of the brain. , 1982, International journal of radiation oncology, biology, physics.
[14] J. Sørensen,et al. Brain relapses in chemotherapy-treated small cell lung cancer: a retrospective review of two time-dose regimens of therapeutic brain irradiation. , 1996, Lung cancer.
[15] L D Lunsford,et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. , 1999, International journal of radiation oncology, biology, physics.
[16] R. Gelber,et al. Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis , 1981, Cancer.
[17] L. Russon,et al. Investigating the palliative efficacy of whole-brain radiotherapy for patients with multiple-brain metastases and poor prognostic features. , 2003, Clinical oncology (Royal College of Radiologists (Great Britain)).
[18] M. Suntharalingam,et al. Comparison of three treatment options for single brain metastasis from lung cancer , 2000, International journal of cancer.
[19] D. Osoba,et al. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires , 1996, Quality of Life Research.
[20] D. Kondziolka,et al. Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: The Patients’ Perspective Regarding Complications , 2005, American journal of clinical oncology.
[21] J. Michalski,et al. Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the Radiation Therapy Oncology Group protocol 91-04. , 2000, International journal of radiation oncology, biology, physics.
[22] M. Yaneva,et al. Assessment of the effect of palliative radiotherapy for cancer patients with intracranial metastases using EORTC-QOL-C30 questionnaire. , 2006, Folia medica.
[23] H. Mogami,et al. Chemotherapy of brain metastases from lung carcinoma: a controlled randomized study. , 1991, Neurosurgery.
[24] B. Stea,et al. Improved Survival, Quality of Life, and Quality-Adjusted Survival in Breast Cancer Patients Treated With Efaproxiral (Efaproxyn) Plus Whole-Brain Radiation Therapy for Brain Metastases , 2007, American journal of clinical oncology.
[25] J. Cairncross,et al. Radation therapy for brain metastases , 1980 .
[26] C. J. Long,et al. Investigation of the Karnofsky Performance Status as a measure of quality of life. , 1984, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[27] T. Phillips,et al. Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05. , 1995, International journal of radiation oncology, biology, physics.
[28] C. Haie-meder,et al. Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[29] Posner Jb. Management of central nervous system metastases. , 1977 .
[30] U. Nestle,et al. Accelerated radiotherapy for brain metastases. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[31] R. Yancik,et al. Assessing the Quality of Life of Cancer Patients , 1990 .
[32] D. Hoegler. Radiotherapy for palliation of symptoms in incurable cancer. , 1997, Current problems in cancer.
[33] E. Rakovitch,et al. Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. , 2005, Cancer treatment reviews.
[34] F. Lohr,et al. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] L. Minasian,et al. Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology Program. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] Thomas J. Smith,et al. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] R. Gelber,et al. Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. , 1981, International journal of radiation oncology, biology, physics.
[38] F. Saran,et al. Stereotactic radiotherapy for solitary brain metastases. , 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).
[39] C. Mansfield,et al. Randomized trial of radiotherapy versus radiotherapy plus metronidazole for the treatment metastatic cancer to brain , 2004, Journal of Neuro-Oncology.
[40] W R Markesbery,et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. , 1998, JAMA.
[41] P. Yang,et al. Late survival of non-small cell lung cancer patients with brain metastases. Influence of treatment. , 1992, Chest.
[42] T Sahmoud,et al. Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] T. Inoue,et al. Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase. , 1994, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].
[44] A. Markoe,et al. The role of hyperfractionated re-irradiation in metastatic brain disease: a single institutional trial. , 1997, American journal of clinical oncology.
[45] J. Dunn,et al. Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases. , 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).
[46] C. Conill,et al. Performance status assessment in cancer patients , 1990, Cancer.
[47] R. Gelber,et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. , 1980, International journal of radiation oncology, biology, physics.
[48] W. Mason,et al. Symptom response after palliative radiotherapy for patients with brain metastases. , 2002, European journal of cancer.
[49] A. Harwood,et al. Radiation therapy of cerebral metastases: a randomized prospective clinical trial. , 1977, International journal of radiation oncology, biology, physics.
[50] R. Mulhern,et al. Quality‐of‐Life Assessment in Cancer Patients , 1988, American journal of clinical oncology.
[51] N. Viñolas,et al. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. , 2005, International journal of radiation oncology, biology, physics.
[52] E. Noordijk,et al. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. , 1994, International journal of radiation oncology, biology, physics.
[53] R. Strohal,et al. Combined Razoxane and Radiotherapy for Melanoma Brain Metastases. A Retrospective Analysis , 2005, Journal of Neuro-Oncology.
[54] G. Krol,et al. The combined use of radiation therapy and lonidamine in the treatment of brain metastases , 1989, Journal of Neuro-Oncology.
[55] I. Tannock. Treating the patient, not just the cancer. , 1987, The New England journal of medicine.
[56] J. Horton,et al. The management of metastases to the brain by irradiation and corticosteroids. , 1971, The American journal of roentgenology, radium therapy, and nuclear medicine.
[57] M. Tsao,et al. Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases. , 2005, Journal of pain and symptom management.
[58] N. Spry,et al. Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05). , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[59] Maria Werner-Wasik,et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial , 2004, The Lancet.
[60] F. Lohr,et al. Adjuvant treatment of brain metastases. , 2001, Seminars in surgical oncology.
[61] W. M. Shehata,et al. Rapid fractionation technique and re‐treatment of cerebral metastases by irradiation , 1974, Cancer.
[62] G. Pond,et al. Prognostic factors in brain metastases: can we determine patients who do not benefit from whole-brain radiotherapy? , 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).
[63] V T Chang,et al. Validation of the Edmonton Symptom Assessment Scale , 2000, Cancer.
[64] R. Gelber,et al. The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group. , 1981, International journal of radiation oncology, biology, physics.
[65] Susan M. Chang,et al. Radiosurgery for brain metastases: is whole brain radiotherapy necessary? , 1999, International journal of radiation oncology, biology, physics.
[66] J. Bellmunt,et al. Treatment of metastatic cancer , 2008 .
[67] H. Eich,et al. Phase I/II Trial of Simultaneous Whole-Brain Irradiation and Dose-Escalating Topotecan for Brain Metastases , 2005, Strahlentherapie und Onkologie.
[68] Michael I. Seider,et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. , 1997, International journal of radiation oncology, biology, physics.
[69] A. Markoe,et al. The Role of Steroids in the Management of Metastatic Carcinoma to the Brain: A Pilot Prospective Trial , 1994, American journal of clinical oncology.
[70] John H. Zhang,et al. Management Strategies for Patients with Brain Metastases: Has Radiosurgery Made a Difference? , 2004, Southern medical journal.
[71] M. Mehta,et al. Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018. , 2002, International journal of radiation oncology, biology, physics.
[72] S. Casciaro,et al. Fractionations in Radiotherapy of Brain Metastases , 2004, Tumori.
[73] D. Cella,et al. The functional assessment of cancer therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT‐G) in patients with primary brain tumors , 1995, Cancer.
[74] S. Reddy,et al. Results of re‐irradiation for cerebral metastases , 1980, Cancer.
[75] Y Maruyama,et al. A randomized trial of surgery in the treatment of single metastases to the brain. , 1990, The New England journal of medicine.
[76] G. Duncan,et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis , 1996, Cancer.
[77] G. Steele,et al. Cancer: Principles and Practice of Oncology , 1983 .
[78] M. Mehta,et al. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[79] M. Mehta,et al. Neurocognitive and Functional Assessment of Patients With Brain Metastases: A Pilot Study , 2003, American journal of clinical oncology.
[80] Ian N. Olver,et al. Observer error in grading performance status in cancer patients , 1999, Supportive Care in Cancer.